HK1045251A1 - Leflunomide產品的抵抗病毒的用途 - Google Patents

Leflunomide產品的抵抗病毒的用途

Info

Publication number
HK1045251A1
HK1045251A1 HK02105067.5A HK02105067A HK1045251A1 HK 1045251 A1 HK1045251 A1 HK 1045251A1 HK 02105067 A HK02105067 A HK 02105067A HK 1045251 A1 HK1045251 A1 HK 1045251A1
Authority
HK
Hong Kong
Prior art keywords
viral
viral uses
leflunomide
products
leflunomide products
Prior art date
Application number
HK02105067.5A
Other languages
English (en)
Inventor
W Williams James
Chong Anita
James Waldman W
Original Assignee
Ohio State Res Found
James Williams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State Res Found, James Williams filed Critical Ohio State Res Found
Publication of HK1045251A1 publication Critical patent/HK1045251A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
HK02105067.5A 1998-03-11 2002-07-08 Leflunomide產品的抵抗病毒的用途 HK1045251A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7755298P 1998-03-11 1998-03-11
PCT/US1999/005326 WO1999045908A2 (en) 1998-03-11 1999-03-11 Anti-viral uses of leflunomide products

Publications (1)

Publication Number Publication Date
HK1045251A1 true HK1045251A1 (zh) 2002-11-22

Family

ID=22138741

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105067.5A HK1045251A1 (zh) 1998-03-11 2002-07-08 Leflunomide產品的抵抗病毒的用途

Country Status (7)

Country Link
EP (1) EP1169036B1 (zh)
JP (1) JP4581137B2 (zh)
AT (1) ATE382349T1 (zh)
AU (1) AU3080299A (zh)
DE (1) DE69937904T2 (zh)
HK (1) HK1045251A1 (zh)
WO (1) WO1999045908A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030187028A1 (en) * 2000-02-28 2003-10-02 Michael Brands Medicament for viral diseases
JP2005104852A (ja) * 2003-09-29 2005-04-21 Kyowa Hakko Kogyo Co Ltd モービリウィルス感染症の予防または治療用組成物
US20060024376A1 (en) * 2004-07-30 2006-02-02 The University Of Chicago Methods and compositions for reducing toxicity associated with leflunomide treatment
EP4108241A1 (en) * 2020-02-18 2022-12-28 East China University of Science and Technology Anti-rna virus drug and application thereof
WO2022171682A1 (fr) * 2021-02-10 2022-08-18 Phytobokaz Composition thérapeutique à base de feuilles de neurolaena inhibitrice de la dhodh pour le traitement d'infections par virus à arn
FR3119539B1 (fr) * 2021-02-10 2023-12-22 Phytobokaz Composition thérapeutique inhibitrice de la DHODH

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174219T1 (de) * 1993-01-08 1998-12-15 Hoechst Ag Verwendung von leflunomid zur hemmung von tumornekrosefaktor alpha
DE59407413D1 (de) * 1993-01-08 1999-01-21 Hoechst Ag Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
JP4408450B2 (ja) * 1994-07-01 2010-02-03 ウェルスタット セラピューティクス コーポレイション 全身性炎症および炎症性肝炎の処置のためのピリミジンヌクレオチド前駆体
DE19711800A1 (de) * 1997-03-21 1998-09-24 Hoechst Ag Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung

Also Published As

Publication number Publication date
AU3080299A (en) 1999-09-27
WO1999045908A3 (en) 2000-01-20
EP1169036A2 (en) 2002-01-09
WO1999045908A2 (en) 1999-09-16
JP4581137B2 (ja) 2010-11-17
EP1169036B1 (en) 2008-01-02
ATE382349T1 (de) 2008-01-15
DE69937904D1 (de) 2008-02-14
JP2003523309A (ja) 2003-08-05
DE69937904T2 (de) 2009-01-02

Similar Documents

Publication Publication Date Title
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
MY120511A (en) New pesticides
ZA200108530B (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents.
IL145213A0 (en) Polyurethane solutions containing allkoxysilane structural units
WO2001060157A3 (en) Antibacterial agents and compositions
WO2002044322A3 (en) Bacteriophage composition useful in treating food products to prevent bacterial contamination
MXPA03000107A (es) Pirroloquinolonas como agentes antivirales.
MXPA03009868A (es) Composiciones de recubrimiento que comprenden productos de carbon de area-t alta.
WO1999054315A3 (de) Triazolone mit neuroprotektiver wirkung
HK1045251A1 (zh) Leflunomide產品的抵抗病毒的用途
MXPA01010026A (es) Composicion acuosa de revestimiento con una mejor adhesion a superficies friales.
GB9807114D0 (en) Novel process
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
GB9930312D0 (en) Improvements in/or relating to the transport of items
MXPA03010498A (es) Proceso para la preparacion de imipenem.
ZA200205260B (en) Compositions for the manufacture of organo-mineral products, products obtained therefrom and their use.
ZA983231B (en) Substituted benzyloxyimino compounds.
MXPA04002104A (es) Anticuerpos contra caspasa-8, su preparacion y uso.
CA97856S (en) Bottle
PL353952A1 (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacycloalkene-2-one
TR200100220T2 (tr) Döşemeli bir ürünün yapımı için işlem
WO2001055198A3 (de) Haut- und magen-spezifischer sphingolipid-aktivator
ES2183543T3 (es) Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
UA31183A (uk) Гірка настоянка
AU2001249404A1 (en) Article carrier and blank